AUTHOR=Godfraind Théophile 

TITLE=Discovery and Development of Calcium Channel Blockers

JOURNAL=Frontiers in Pharmacology

VOLUME=Volume 8 - 2017

YEAR=2017

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00286

DOI=10.3389/fphar.2017.00286

ISSN=1663-9812

ABSTRACT=ABSTRACT

In the mid nineteen sixties, experimental work on molecules under screening as coronary dilators allowed the discovery of the mechanism of calcium entry blockade by drugs later named calcium channel blockers. This paper summarizes scientific research on these small molecules interacting directly with L-type voltage-operated calcium channels. It also reports on experimental approaches translated into understanding of their therapeutic actions.

The importance of calcium in muscle contraction was discovered by Sidney Ringer who reported this fact in 1883. Interest in the intracellular role of calcium arose 60 years later out of Kamada (Japan) and Heibrunn (USA) experiments in the early nineteen forties. Studies on pharmacology of calcium function were initiated in the mid nineteen sixties and their therapeutic applications globally occurred in the the nineteen eighties.

The first part of this report deals with basic pharmacology in the cardiovascular system particularly in isolated arteries.
In the section entitled from calcium antagonists to calcium channel blockers, it is recalled that drugs of a series of diphenylpiperazines screened in vivo on coronary bed precontracted by angiotensin were initially named calcium antagonists on the basis of their effect in depolarized arteries contracted by calcium. Studies on arteries contracted by catecholamines showed that the vasorelaxation resulted from blockade of calcium entry. Radiochemical and electrophysiological studies performed with dihydropyridines allowed their cellular targets to be identified with L-type voltage-operated calcium channels. The modulated receptor theory helped the understanding of their variation in affinity dependent on arterial cell membrane potential and promoted the terminology calcium channel blocker (CCB) of which the various chemical families are introduced in the paper.
In the section entitled tissue selectivity of calcium channel blockers, it is shown that characteristics of the drug, properties of the tissue and of the stimuli are important factors of their action. The high sensitivity of hypertensive animals is explained by the partial depolarization of their arteries. It is noted that they are arteriolar dilators and that they cannot be simply considered as vasodilators.

The second part of this report provides key information about clinical usefulness of calcium channel blockers.
A section is devoted to the